NCT02078102 2021-02-21
A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
Indiana University
Phase 2 Completed
Indiana University
Major Extremity Trauma Research Consortium
Massachusetts General Hospital
University Health Network, Toronto